Vimarsana
Biggest News Aggregation in the World

Page 22 - Roche Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Diagnostics Today - Breaking & Trending Today

DalCor Pharmaceuticals Closes USD80M Series D Financing - Vimarsana News

DalCor Pharmaceuticals Closes USD80M Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Myocardial Injury After Cardiac Surgery: Time for New hs-cTnT Thresholds? - Vimarsana News

Myocardial Injury After Cardiac Surgery: Time for New hs-cTnT Thresholds?

A retrospective review hints that using hs-troponin to predict events after CV surgery warrants rethinking definitions of “high.”

Source: tctmd.com
Polymerase Chain Reaction (PCR) Market Size to Surpass USD - Vimarsana News

Polymerase Chain Reaction (PCR) Market Size to Surpass USD

As per the report by Fortune Business Insights, the global Polymerase Chain Reaction (PCR) Market size is projected to reach USD 13.75 billion in 2028, at...

Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland - Vimarsana News

Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland

Background The COVID-19 pandemic disrupted the continuing management of cardiovascular disease (CVD) risk factors in the population. Socioeconomic status (SES) is a major determinant of health. Whether the COVID-19 pandemic increased, the SES gap in CVD risk factors is unknown. Aims To compare the management of CVD risk factors and the SES gap before and during the pandemic. Methods Cross-sectional study conducted between 2018 and 2021 in Lausanne, Switzerland. Prevalence, awareness, treatment and control rates of hypertension, dyslipidaemia and diabetes were compared between the periods befor...

Source: bmj.com
Antimicrobial Resistance Surveillance Market worth $7.7 billion - Vimarsana News

Antimicrobial Resistance Surveillance Market worth $7.7 billion

/PRNewswire/ -- In the near future, the antimicrobial resistance surveillance industry is poised to undergo a transformative evolution, driven by advances in...